UK company record
Nuclera
Synthetic biology / protein & antibody engineering hardware
CandidateCore UK
Snapshot
- UK location
- Cambridge · East of England
- Sector
- Biotech & techbio
- Latest recorded round
- Series C
- Latest recorded amount
- $87M total (incl. $12M extension)
- Date
- 2026-01-01
Legal-identity layer
Candidate identity.
- Selected legal name
- NUCLERA LTD
- Company number
- 08663936
- Companies House status
- active
- Incorporated
- 2013-08-27
Investors
- British Business BankParticipant
- Cambridge Innovation CapitalParticipant
- Elevage Medical TechnologiesLead
- GK GohParticipant
- Jonathan MilnerLead
Current directors and active controllers
- CHEN, Michael Chun Hao, DrCurrent director
- KEEGAN, Joseph, DrCurrent director
- KULLBACK, William JayCurrent director
- MCCREARY, Michael, DrCurrent director
- MILNER, Jonathan Simon, DrCurrent director
- TAYLOR WESSING SECRETARIES LIMITEDCurrent director
- VENKATESAN, Bala MuraliCurrent director
- WASSERMAN, MichaelCurrent director
- Dr Gordon Ross McinroyFormer controller
- Dr Jiahao HuangFormer controller
- Dr Michael Chun Hao ChenFormer controller
- GOUGH, Alexander Philipdirector
- HERLING-MCINROY, Gordon Ross, Drdirector
- HUANG, Jiahao, Drdirector
- LAZAR, Radu Alexandrudirector
- MARTIN, Barnaby Hugo Domnicdirector
Funding rows
- Series C$75M · 2024-10-16
- Series C extension$12M additional (Series C total $87M) · 2026-01-13